Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin polyglutamylase complex subunit 1 (TPGS1) is a protein encoded by the TPGS1 gene, serving as a subunit of the tubulin polyglutamylase complex (TPGC)[1][4]. This complex mediates polyglutamylation, a post-translational modification of microtubule proteins (tubulin) essential for the biogenesis and motility of cilia and flagella[4][1]. TPGS1 is involved in microtubule binding and may participate in targeting the polyglutamylase complex to specific substrates, particularly relevant in sperm axoneme assembly and potentially other microtubule-related processes[1][4]. Loss or dysregulation of tubulin polyglutamylation has been linked to neuronal dysfunction and degeneration, reflecting the critical role of this modification in neurobiology, although specific direct disease-causing variants of TPGS1 gene have not been established[5][3]. While the polyglutamylation machinery features as an important regulator of microtubule function, TPGS1 itself is not a canonical therapeutic target such as a receptor, enzyme, transporter, or channel in current medical research[1][4]. There are no drugs or biomarkers directly linked to TPGS1, and its therapeutic targeting is not currently established[1][4]. References to the polyglutamylase complex implicate broader roles in regulating the interaction of microtubules with associated proteins (MAPs), motor proteins, and enzymes, thereby affecting processes like neuronal signaling and cytoskeletal dynamics, but TPGS1 as an individual subunit has not been separately targeted or characterized for intervention[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin polyglutamylase complex subunit 1 (TPGS1).